Brussels South Charleroi BioPark
Brussels South Charleroi BioPark
Description
Created in 1999 by the Université Libre de Bruxelles (ULB), Charleroi BioPark houses around 108 companies and involves 3,700 individuals in research, development, and production of new drugs, medical devices, and diagnostic methods.
These endeavors span diverse fields, including oncology, immune diseases, cell and gene therapy, vaccines, and neurodegenerative diseases, among others.
Charleroi BioPark accommodates subsidiaries of major international corporations like Catalent and Thermo Fisher Scientifics, SMEs from various countries (France, Spain, Canada, China,..) and Belgian companies that have ascended to global leadership positions like the Univercells Group supported by the Bill and Melinda Gates Foundation or Iteos Therapeutics a Nasdaq listed company.
The growth of the campus is supported by three research institutes affiliated with two universities ULB and UMONS, a dedicated training center ULB-HELSCI and the BioPark Incubator.
These endeavors span diverse fields, including oncology, immune diseases, cell and gene therapy, vaccines, and neurodegenerative diseases, among others.
Charleroi BioPark accommodates subsidiaries of major international corporations like Catalent and Thermo Fisher Scientifics, SMEs from various countries (France, Spain, Canada, China,..) and Belgian companies that have ascended to global leadership positions like the Univercells Group supported by the Bill and Melinda Gates Foundation or Iteos Therapeutics a Nasdaq listed company.
The growth of the campus is supported by three research institutes affiliated with two universities ULB and UMONS, a dedicated training center ULB-HELSCI and the BioPark Incubator.
Referent Contact
Dominique DEMONTE
dominique@biopark.be
Brussels South Charleroi BioPark
Address
48 Rue Auguste Piccard
6041 Charleroi, Belgique
6041 Charleroi, Belgique
Contact
dominique@biopark.be
Description
Created in 1999 by the Université Libre de Bruxelles (ULB), Charleroi BioPark houses around 108 companies and involves 3,700 individuals in research, development, and production of new drugs, medical devices, and diagnostic methods.
These endeavors span diverse fields, including oncology, immune diseases, cell and gene therapy, vaccines, and neurodegenerative diseases, among others.
Charleroi BioPark accommodates subsidiaries of major international corporations like Catalent and Thermo Fisher Scientifics, SMEs from various countries (France, Spain, Canada, China,..) and Belgian companies that have ascended to global leadership positions like the Univercells Group supported by the Bill and Melinda Gates Foundation or Iteos Therapeutics a Nasdaq listed company.
The growth of the campus is supported by three research institutes affiliated with two universities ULB and UMONS, a dedicated training center ULB-HELSCI and the BioPark Incubator.
These endeavors span diverse fields, including oncology, immune diseases, cell and gene therapy, vaccines, and neurodegenerative diseases, among others.
Charleroi BioPark accommodates subsidiaries of major international corporations like Catalent and Thermo Fisher Scientifics, SMEs from various countries (France, Spain, Canada, China,..) and Belgian companies that have ascended to global leadership positions like the Univercells Group supported by the Bill and Melinda Gates Foundation or Iteos Therapeutics a Nasdaq listed company.
The growth of the campus is supported by three research institutes affiliated with two universities ULB and UMONS, a dedicated training center ULB-HELSCI and the BioPark Incubator.
Matchmaking
Connect with Brussels South Charleroi BioPark
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways